Skip to main content
Share

World's leading clinical conference on bone, joint and muscle health

Programme

Go to Sponsored Sessions

Thursday April 10 th - CEST Timezone

13:00 - 16:00
Auditorium A
Symposium: Osteoporosis & Chronic Kidney Diseases – Metabolic Bone Diseases under the Same Umbrella
Chairpersons: David Dempster, Nicholas C. Harvey
13:00
Auditorium A
Introduction - Osteoporosis vs Renal Osteodystrophy
Pieter Evenepoel
13:20
Auditorium A
Bone Histology - Osteoporosis vs Renal Osteodystrophy
David Dempster
13:40
Auditorium A
Diagnosis: Biochemistry, Imaging - Osteoporosis vs Renal Osteodystrophy
Thomas L. Nickolas
14:00
Auditorium A
Discussion
14:20
Auditorium A
Courtesy Break
14:40
Auditorium A
Vascular Calcification in Chronic Kidney Diseases - Metabolic Bone Diseases & associated Osteoporosis
Ziad Massy
15:00
Auditorium A
Current Therapeutic Options - Osteoporosis & Renal Osteodystrophy
Sandro Mazzaferro
15:20
Auditorium A
Intermittent PTH Administration in the Management of Chronic Kidney Diseases - Metabolic Bone Diseases
Michael Pazianas
15:40
Auditorium A
Discussion
16:30 - 19:10
Auditorium A
WCO-IOF-ESCEO - OPENING CEREMONY
Chairpersons: René Rizzoli, Nicholas C. Harvey
16:30
Auditorium A
Best clinical papers published in 2024
René Rizzoli
17:10
Auditorium A
Opening of the congress
René Rizzoli, Nicholas C. Harvey
17:15
Auditorium A
Two years of partnership between WHO and ESCEO: Achievements and perspectives
Doctor Jotheeswaran Amuthavalli Thiyagarajan (WHO-Geneva)
17:25
Auditorium A
Presentation of the Islene Araujo de Carvalho-ESCEO 2025 Prize
Doctor Jotheeswaran Amuthavalli Thiyagarajan (WHO-Geneva), Jean-Yves Reginster
17:30
Auditorium A
Partnering for Progress: Global Drug Development and Scientific Societies
Bruno Sepodes
17:40
Auditorium A
Presentation of the ESCEO-IOF Pierre Delmas Medal
Jean-Yves Reginster
17:45
Auditorium A
Revival of the European Medicines Agency activities oriented towards older people
Francesca Cerreta
17:55
Auditorium A
Presentation of the IOF President's Award
Nicholas C. Harvey
18:00
Auditorium A
New Perspectives in the management of patients with osteoporosis
Willard Dere
18:30
Auditorium A
Presentation of the 2025 ESCEO Medal of Excellence
René Rizzoli
18:35
Auditorium A
Highlights of the Galleria Borghese
Francesca Cappelletti
19:05
Auditorium A
Closure of the Opening Ceremony Session and Opening of the Cocktail
Jean-Yves Reginster

Friday April 11 th - CEST Timezone

08:00
Opening of the Congress & commercial exhibition
08:00 - 09:00
Non-Sponsored Symposia
08:00
MR2
Update in Low Back Pain: Diagnosis, Guidelines and Management
Chairpersons: Fitnat Dincer, Andreas Winkelmann
08:00
MR2
Approach of physiatrists to Low Back Pain in Europe, results of a research and WHO guideline
Fitnat Dincer
08:00
MR2
Update in Diagnosis and Management of Low Back Pain
Andreas Winkelmann
08:00
MR3
Empowering Patients: Integrating Preferences and Perspectives into Osteoporosis Care and Policy Development
Chairperson: Angie Botto-van Bemden
08:00
MR3
What Do We Know About Preferences of Patients at Risk for Fractures?
Lakshmi Nagendra
08:00
MR3
Integrating Patients Preferences and Perspectives into Osteoporosis Care and Policy Development: An Academic Perspective
Mickael Hiligsmann
08:00
MR3
Integrating Patient Preferences and Perspectives into Osteoporosis Care and Policy Development: The Patient Perspective
Angie Botto-van Bemden
08:00
MR4
Muscle And Bone: A Multifaceted Connection
Chairperson: Osvaldo Daniel Messina
08:00
MR4
A message from the bone: how bone-secreted factors affect muscle growth and function
Gustavo Duque
08:00
MR4
The role of fat in muscle/bone crosstalk: an additional complex player
Tiffany Kim
08:00
MR4
A message from the muscle: how muscle-secreted factors affect bone metabolism and function
Osvaldo Daniel Messina
08:00
MR1
Management of osteoporotic vertebral fractures - Risk factor - Guidelines - Technology
Chairpersons: Andreas Kurth, Chistopher Niedhardt
08:00
MR1
Risk factor vertebral fractures
Peyman Hadji
08:00
MR1
German Guidelines for the Treatment of vertebral osteoporotic fractures
Andreas Kurth
08:00
MR1
30 Years of Vertebro- and Kyphoplasty
Robert Pflugmacher
08:00
MR6
Optimization of bone health in orthopaedic surgical patients
Chairperson: P. Dean Cummings
08:00
MR6
Underlying Bone Health: Is it Important to Surgical Outcomes?
P. Dean Cummings
08:00
MR6
Orthopaedic Surgeries Affected by Compromised Bone Health
Nikos Koumontzis
08:00
MR6
Development of Pre- and Post-operative Bone Health Programs for Orthopedic Surgical Patients
Isabella Esposito
08:00
MR7
Hyponatremia and Bone
Chairpersons: Maria Luisa Brandi, Alessandro Peri
08:00
MR7
What did basic research tell us?
Alessandro Peri
08:00
MR7
Hyponatremia and bone density
Laura Potasso
08:00
MR7
Hyponatremia, falls and fractures
Ploutarchos Tzolis
08:00
MR7
Discussion and Conclusion
08:00
MR8
Discovery, validation and implementation of endophenotyping for patient stratification in osteoarthritis clinical trials
Chairperson: Ali Mobasheri
08:00
MR8
Advancing osteoarthritis trials and therapeutic development through clinical phenotyping and molecular endotyping
Ali Mobasheri
08:00
MR8
Endotyping osteoarthritis by interrogating the pathobiological bioactivity present in osteoarthritic synovial fluid
Tim J. M. Welting
08:00
MR8
Insights into OA endophenotypes from recent clinical trials
Philip Conaghan
08:00
MR8
Obesity shapes the inflammatory molecular endotypes of synovial fibroblasts in osteoarthritis
Simon W. Jones
08:00
MR8
Clinical application of longitudinally stable molecular endotypes in osteoarthritis: pathways to precision medicine
Anne-Christine Bay-Jensen
08:00
MR10
The skeleton in the Closet: A historical look at osteoporosis
Chairperson: Bruno Muzzi Camargos
08:00
MR10
Osteoporosis in Ancient History
Geraldine Altamar
08:00
MR10
Osteoporosis in Art
Andres Coy
08:00
MR10
History of Osteoporosis pharmacological treatment
Michael McClung
08:00 - 09:00
MR5
ESCEO Symposium: Recommendations for an optimal use of Bone Forming Agents in osteoporosis
Chairpersons: Bernard Cortet, Nicola Veronese
08:00
MR5
Which patients should benefit from a Bone Forming Agent?
Elizabeth M. Curtis
08:00
MR5
Comparative efficacy and safety of currently available Bone Forming Agents
René Rizzoli
08:00
MR5
Discussion Leader
Peter R. Ebeling
09:00 - 10:30
Auditorium A
Scientific Session I
Chairpersons: Elaine M. Dennison, Salvatore Minisola
09:00
Auditorium A
Plenary Lecture
Hormone therapy for fracture prevention - a sex stratified approach
Michael McClung
Have a sneak peek
09:30
Auditorium A
Oral communications selected from abstracts
OC1: AGA2118, A BISPECIFIC MONOCLONAL ANTIBODY NEUTRALIZING BOTH SCLEROSTIN AND DKK1, INCREASED BONE FORMATION, DECREASED BONE RESORPTION, AND LED TO RAPID BMD GAINS IN A FIRST IN HUMAN, SINGLE- AND MULTIPLE- DOSE, PLACEBO-CONTROLLED, RANDOMIZED STUDY
Presenting author: B. Langdahl
Authors: M. T. Drake, Y. L. Zhang, J. Z. Ke, Y. F. Li, M. Lankachandra, A. C. Zovein, H. Z. Ke, W. H. Dere & R. E. Dent
09:40
Auditorium A
Oral communications selected from abstracts
OC2: WEEKLY VITAMIN D AND DAILY CALCIUM CARBONATE OVER 48-WEEKS INCREASES BONE DENSITY IN ADOLESCENTS WITH HIV AND 25(OH)D <75NMOL/L: A PLACEBO-CONTROLLED TRIAL IN SOUTHERN AFRICA
Presenting author: C. Gregson
Authors: T. Madanhire, N. V. Dzavakwa, L. Kasonka, H. Banda-Mabuda, T. Bandason, M. Chisenga, S. Filteau, K. Kranzer, H. Mujuru, U. E. Schaible, S. L. Rowland-Jones, V. Simms & R. A. Ferrand
09:50
Auditorium A
Oral communications selected from abstracts
OC3: PTH1 RECEPTOR AGONISTS FOR FRACTURE RISK: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
Presenting author: C. Beaudart
Author: N. Veronese, J. Douxfils, J. Amuthavalli Thiyagarajan, F. Bolzetta, P. Albanese, G. Voltan, M. Alokail, N. C. Harvey, N. R. Fuggle, R. Rizzoli & J.-Y. Reginster
10:00
Auditorium A
Oral communications selected from abstracts
OC4: EFFECTS OF EB613 TABLETS [ORAL PTH(1-34)] ON TRABECULAR AND CORTICAL BONE USING 3D-DXA: POST-HOC RESULTS FROM PHASE 2 STUDY
Presenting author: R. Wagman
Author: G. Burshtein, C. Itin, H. Galitzer, M. Kushnir, M. Toledano, L. Humbert, R. Boyce, S. L. Ferrari & F. Cosman
10:10
Auditorium A
Oral communications selected from abstracts
OC5: SUSTAINED REDUCTION IN FRACTURE RATE IN PATIENTS WITH OI TREATED WITH SETRUSUMAB: FOURTEEN MONTH DATA FROM PHASE 2 OF THE PHASE 2/3 ORBIT STUDY
Presenting author: J. Nowicki
Author: S. Gottesman, O. Carpenter, D. Velasco, M. Wallace, P. Smith, A. Imel, D. Luca, M. Byers, S. Krolczyk & E. M. Lewiecki
10:20
Auditorium A
Oral communications selected from abstracts
OC6: PROGRESSIVE DECREASES IN FRACTURE INCIDENCE WITH ZOLEDRONATE USE >3 YEARS
Presenting author: I. Reid
Author: A. M. Horne, B. Mihov & G. D. Gamble
10:30 - 12:10
Auditorium A
Scientific Session II
Chairpersons: Jean-Marc Kaufman, Maria Luisa Brandi
10:30
Auditorium A
Presentation of the 2025 IOF CSA Medal of Achievement
Eugene McCloskey
10:40
Auditorium A
Plenary Lecture
Anti-resorptives: series or parallel ?
Eugene McCloskey
11:10
Auditorium A
Oral communications selected from abstracts
OC7: COMPREHENSIVE COMPARATIVE ANALYSIS OF INFRAPATELLAR FAT PAD MORPHOLOGIES IN A LONGITUDINAL KNEE OSTEOARTHRITIS STUDY: NEW INSIGHTS INTO ITS ROLE AS A PROGNOSTIC MARKER
Presenting author: J.-P. Pelletier
Author: P. Paiement, F. Abram, M. Dorais, J.-P. Raynauld & J. Martel-Pelletier
11:20
Auditorium A
Oral communications selected from abstracts
OC8: RESULTS FROM A RANDOMISED CONTROLLED PHASE II TRIAL WITH LEVI-04, A NOVEL NEUROTROPHIN-3 INHIBITOR, DEMONSTRATE SUBSTANTIALLY IMPROVED PAIN AND FUNCTION WITHOUT DELETERIOUS EFFECTS ON JOINT STRUCTURE IN PEOPLE WITH KNEE OSTEOARTHRITIS
Presenting author: P. Conaghan
Author: A. Guermazi, N. Katz, A. Bihlet, R. Dror, M. Perkins, B. Hughes, C. Herholdt, I. Bombelka & S. Westbrook
11:30
Auditorium A
Oral communications selected from abstracts
OC9: A PHASE 1B RANDOMIZED CONTROLLED TRIAL EVALUATING SAFETY AND PHARMACODYNAMICS OF A NOVEL IL-1RA GENE THERAPY (GNSC-001) INJECTION IN KNEE OA: 6-MONTH INTERIM RESULTS
Presenting author: J. Tambiah
Author: S. Jackson, M. Concepcion, S. Vijay, T. W. Chalberg, A. Annahita & P. G. Conaghan
11:40
Auditorium A
Oral communications selected from abstracts
OC10: EFFECTIVENESS OF CELECOXIB IN REDUCING OSTEOARTHRITIS (OA) PAIN IN PATIENTS WITH MODERATE AND SEVERE PAIN: ONCE-DAILY VS TWICE-DAILY DOSING
Presenting author: E. Choy
Author: C. Walker, R. Chiaese, E. Biesheuvel & S. Suresh Kumbhar
11:50
Auditorium A
Oral communications selected from abstracts
OC11: 10-YEAR FOLLOW-UP AFTER INTRA-ARTICULAR INJECTIONS OF 2.5 % POLYACRYLAMIDE HYDROGEL FOR KNEE OSTEOARTHRITIS
Presenting author: H. Bliddal
Author: A. Hartkopp, P. Conaghan & M. Henriksen
12:00
Auditorium A
Oral communications selected from abstracts
OC12: EFFECTS OF INTRA-ARTICULAR HYALURONIC ACID INJECTIONS ON PAIN AND FUNCTION IN KNEE OSTEOARTHRITIS PATIENTS: AN UMBRELLA REVIEW OF SYSTEMATIC REVIEWS AND META-ANALYSES OF RANDOMIZED PLACEBO-CONTROLLED TRIALS
Presenting author: O. Bruyère
Author: M. Alokail, N. Al-Daghri, J.-Y. Reginster & S. Sabico
14:00 - 15:00
Podium
Oral presentations of selected posters
Chairperson: Fanny Buckinx
14:00
Podium
OP1 - P815: OBESITY IS RELATED TO POORER FUNCTIONAL OUTCOMES AMONG INDIVIDUALS WITH RADIOGRAPHIC KNEE OSTEOARTHRITIS: FINDINGS FROM THE HERTFORDSHIRE COHORT STUDY
Presenting author: L.D. Westbury
Author: F. Laskou, F. Kirkham-Wilson, G. Bevilacqua, N. R. Fuggle & E. M. Dennison
14:06
Podium
OP2 - P700: DRIVING KNEE OSTEOARTHRITIS STRUCTURAL PROGRESSOR PROGNOSIS INTO THE NEXT GENERATION: LEVERAGING MACHINE/DEEP LEARNING, MICRORNA AND MAGNETIC RESONANCE IMAGING
Presenting author: J. Martel-Pelletier
Author: A. Jamshidi, O. Espin-Garcia, T. G. Wilson, I. Loveless, J.-P. Pellletier & S. A. Ali
14:12
Podium
OP3 - P686: EFFECTIVENESS OF PRESCRIPTION GLUCOSAMINE SULFATE (PGS) IN A COHORT OF FILIPINO PATIENTS WITH MILD-MODERATE KNEE OSTEOARTHRITIS (OA)
Presenting author: J.J. Lichauco
Author: C. Walker, R. Chiaese, H. Scott & S. Venugopal
14:18
Podium
OP4 - P1138: SAFETY OF ANTI-OSTEOARTHRITIS MEDICATIONS: OUTCOMES OF A SYSTEMATIC LITERATURE REVIEW OF POST-MARKETING SURVEILLANCE STUDIES
Presenting author: O. Bruyère
Author: G. Honvo, L. Lengelé, M. Alokail, N. Al-Daghri, J.-Y. Reginster
14:24
Podium
OP5 - P553: EFFECT OF TIBOLONE ON CORTICAL AND TRABECULAR BONE IN POSTMENOPAUSAL WOMEN COMPARED WITH ESTROGEN THERAPY
Presenting author: G.A. Cruz Priego
Author: P. Clark, M.-A. Guagnelli, L. Humbert, S. Ortiz-Santiago, L. Castrejón-Delgado & M. A. Sánchez-Rodriguez
14:30
Podium
OP6 - P817: VERTEBRAL FRACTURES IDENTIFIED ON LATERAL DXA IMAGES USING DEEP NEURAL NETWORKS PREDICT INCIDENT FRACTURES IN OLDER WOMEN
Presenting author: L. Johansson
Authors: V. Wåhlstrand, J. Alvén, I. Häggström & M. Lorentzon
14:36
Podium
OP7 - P381: MACHINE LEARNING FOR THE PREDICTION OF FRAGILITY FRACTURES BY BONE AND BODY COMPOSITION PARAMETERS: FINDINGS FROM THE OSTEOLAUS 10 YEARS POPULATIONAL COHORT
Presenting author: C. Vendrami
Author: G. Gatineau, E. Gonzalez Rodriguez, O. Lamy, D. Hans & E. Shevroja
14:42
Podium
OP8 - P485: REMS TECHNOLOGY FOR FRACTURE RISK ASSESSMENT IN KIDNEY TRANSPLANT PATIENTS
Presenting author: F.A. Lombardi
Author: P. Pisani, F. Conversano, C. Stomaci, F. R. Contaldo, E. Casciaro, G. Peluso, A. C. Stetco, R. Franchini, M. Di Paola & S. Casciaro
14:48
Podium
OP9 - P940: IMPACT OF AI-ENABLED VERTEBRAL FRACTURE (VF) IDENTIFICATION ON FRACTURE LIAISON SERVICE (FLS) KEY PERFORMANCE INDICATORS (KPIS) AND TREATMENT RECOMMENDATIONS VARIES BY FLS
Presenting author: K. Javaid
Author: F. A. A. Clemeno, D. Chappell, J. Connor, J. Threlkeld, C. Chisholm, K. E. S. Poole, J. Boylan, J. Turton, M. Stone, C. Toogood, T. Santos, M. Sampson, M. Baxter, E. Curtis, R. Eckert, O. Sahota, Y. Kimmel & R. Pinedo-Villanueva
14:54
Podium
OP10 - P724: TRENDS IN HIP FRACTURE INCIDENCE IN ENGLAND BEFORE, DURING, AND AFTER THE COVID-19 PANDEMIC (2014-2023)
Presenting author: J. Webster
Author: R. Goldacre
14:00 - 15:00
Poster Viewing Session I
14:00 - 15:00
Meet-The-Expert Session
14:00
MR4
Advances in management of osteogenesis imperfecta
Maria Luisa Brandi
14:00
MR1
Influences of parental health on the next generation bone
Elizabeth M. Curtis, Rebecca Moon
14:00
MR2
Paget’s disease of bone: management lessons from pivotal studies
Elaine M. Dennison
14:00
MR3
Fracture risk in cancer survivors: bone fragility beyond metastases
Cyrille Confavreux
14:00 - 15:00
MR8
Educational Lecture
14:00
MR8
Lessons from interventional studies conducted in sarcopenia: are we close to a treatment?
Francesco Landi
14:00 - 15:00
MR6
ESCEO Symposium: Impact of central nervous system dysfunctions (Dementia and Mild Cognitive Impairment) on bone health in older people
Chairpersons: René Rizzoli, Andrea Ticinesi
14:00
MR6
Relation between cognitive impairment and bone health
Mario Miguel Coelho Da Silva Rosa
14:00
MR6
Drugs used in cognitive impairment and bone health
Ewa Balkowiec-Iskra
14:00
MR6
Discussion leader
Maria Concepcion Prieto Yerro
14:00 - 15:00
MR7
ESCEO-IOF-IFCC Symposium: Update on the role of Bone Turnover Markers in the diagnosis and management of osteoporosis
Chairpersons: Andrea Laslop, Etienne Cavalier
14:00
MR7
Why and how should we test biochemical markers of bone turnover in 2025?
Harjit Pal Bhattoa
14:00
MR7
What do bone turnover markers bring to the clinician, in the screening, diagnosis and monitoring of osteoporosis in 2025?
Stuart L. Silverman
14:00
MR7
What is the role of bone turnover markers in Chronic Kidney Disease-related osteoporosis?
Mathias Loberg Haarhaus
14:00
MR7
Discussion leader
Etienne Cavalier
15:00 - 17:00
Auditorium A
Scientific Session III
Chairpersons: Bess Dawson-Hughes, Leith Zakraoui
15:00
Auditorium A
Plenary Lecture
Osteoanabolics: to lump or to split?
Jean-Yves Reginster
Have a sneak peek
15:30
Auditorium A
Oral communications selected from abstracts
OC13: ASSESSING BONE MINERAL DENSITY: A COMPARATIVE STUDY OF DXA AND RADIOFREQUENCY ECHOGRAPHIC MULTI-SPECTROMETRY (REMS) IN ASIAN POPULATION
Presenting author: Y. Yoshino
Author: Y. Asada, E. Tomatsu, S. Sekiguchi-Ueda, S. Shibata, T. Takayanagi, Y. Seino, Y. Sasaki, H. Takai, H. Ito, H. Sasaki & A. Suzuki
15:40
Auditorium A
Oral communications selected from abstracts
OC14: RAPID BONE MICROARCHITECTURE DECLINE, BUT NOT HIGHER FRACTURE RISK, IN MEN WITH ELEVATED FGF23 CONCENTRATION – THE STRAMBO STUDY
Presenting author: P. Szulc
Author: D. Whittier, S. K. Boyd, L. C. Hofbauer & R. Chapurlat
15:50
Auditorium A
Oral communications selected from abstracts
OC15: NUMBER OF FRACTURES AND FRACTURE INCIDENCE IN RELATION TO BONE MINERAL DENSITY: AN INTERNATIONAL META-ANALYSIS
Presenting author: H. Johansson
Authors: N. C. Harvey, E. McCloskey, E. Liu, L. Vandenput, M. Lorentzon, W. D. Leslie, J. A. Kanis & Frax Meta-Analysis Cohort Group
16:00
Auditorium A
Oral communications selected from abstracts
OC16: TYPE I DIABETES MELLITUS IS ASSOCIATED WITH INCREASED FRACTURE RISK INDEPENDENT OF BONE MINERAL DENSITY: AN INTERNATIONAL META-ANALYSIS
Presenting author: N.C. Harvey
Authors: E. M. Curtis, H. Johansson, E. V. McCloskey, E. Liu, L. Vandenput, M. Lorentzon, W. D. Leslie, J. A. Kanis & Frax Meta-Analysis Cohort Group
16:10
Auditorium A
Oral communications selected from abstracts
OC17: EXTERNAL VALIDATION OF AN AI-DRIVEN RADIOGRAPHIC TOOL FOR OPPORTUNISTIC DETECTION OF HIGH BONE FRAGILITY RISK IN DIVERSE INTERNATIONAL COHORTS
Presenting author: G. Gatineau
Author: M. De Gruttola, K. Hind, M- Davies, M. Kužma, J. Payer, G. Guglielmi, A. Fahrleitner-Pammer, KJ. Chun, K. Jones, D. Krueger, N. Binkley & D. Hans
16:20
Auditorium A
Oral communications selected from abstracts
OC18: COST-EFFECTIVENESS OF OPPORTUNISTIC OSTEOPOROSIS SCREENING USING CHEST RADIOGRAPHS WITH DEEP LEARNING IN GERMANY
Presenting author: M. Hiligsmann
Author: J.-Y. Reginster
16:30
Auditorium A
Plenary Lecture
Obesity stratification in personalised osteoporosis management
Peter R. Ebeling
Have a sneak peek
15:00 - 16:45
MR5
Committee of National Societies Special Plenary Session: Fragility Fracture Management – Challenges and Solutions
Chairpersons: Famida Jiwa, Şansin Tüzün
15:10
MR5
OCs1: TARGETING THE MUSCLE–BRAIN AXIS: THE RECIPROCAL RELATIONSHIP BETWEEN COGNITIVE IMPAIRMENT AND SARCOPENIA- DOES IT REPRESENT A NEW PARADIGM IN SARCOPENIA?
Presenting author: Y. El Miedany
Author: N. Gadallah, M. Sarhan, M. Elgaafary, W. Hassan, N. El Gharbawy, S. Moussa, S. Fathi, N. Fouda, D. El Mikkawy, O. Saboony, A. Safar, W. Elwakil, S. Mahran, M. Elkaramany, N. M. Ahmed, M. Y. Mahgoub & A. Samir
15:18
MR5
OCs2: EVIDENCE-BASED JOINT STATEMENT POSITION OF PERIOPERATIVE BONE OPTIMIZATION IN THE ARTHROPLASTY CANDIDATE, FROM 7 NATIONAL SOCIETIES
Presenting author: R.E. Lopez Cervantes
Author: F. Torres-Naranjo, I. Etxebarria-Foronda, C. Ojeda-Thies, F. Linares-Restrepo, M. A. González-Reyes, J. R. Caeiro-Rey & D. E. Garin-Zertuche
15:26
MR5
OCs3: ACCURACY OF ARTIFICIAL INTELLIGENCE FOR VERTEBRAL FRACTURE ASSESSMENT BY DXA SCAN
Presenting author: O. Phruetthiphat
Author: P. Sinlapavilawan & K. Homsapaya
15:34
MR5
OCs4: GLP-1 RECEPTOR AGONISTS AND RISK OF BONE FRACTURES IN ELDERLY PEOPLE WITH TYPE 2 DIABETES
Presenting author: P. Rotman-Pikielny
Author: M. Kasher Meron, T. Hornik-Lurie & G. Twig
15:42
MR5
OCs5: SARCOPENIA AND ELECTROCARDIOGRAPHIC MARKERS OF ARRHYTHMIA RISK IN OLDER ADULTS
Presenting author: D. Seyithanoglu
Author: O. Erdogan, T. Erdogan, Z. Fetullahoglu, D. Erbas Sacar, O. Kumet, S. Ozkok, M. A. Karan & G. Bahat
15:50
MR5
Presentation of the IOF Committee of National Societies Medal
Famida Jiwa, Şansin Tüzün
16:00
MR5
OCs6: AN ARTIFICIAL INTELLIGENCE ALGORITHM TO IMPROVE DIAGNOSIS OF VERTEBRAL FRACTURES EMBEDDED IN FRACTURE LIAISON SERVICES CAN REDUCE FRACTURES AND REDUCE COSTS
Presenting author: R. Pinedo-Villanueva
Author: G. Fabiano, F. Clemeno & M. K. Javaid
16:08
MR5
OCs7: HIGH-DOSE VITAMIN D THERAPY (300,000 IU MONTHLY): IMPLICATIONS FOR OSTEOARTHRITIS, OSTEOPOROSIS AND ARTERIAL STIFFNESS IN VITAMIN-D DEFICIENT PATIENTS
Presenting author: S. Sokolovic
Author: I. Sokolovic-Tahtovic
16:16
MR5
OCs8: DESTRESSING MINDS. STRENGTHENING MUSCLES. YOGA AND ITS EFFECT ON MUSCLE STRENGTH IN HEALTHY INDIVIDUALS. A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Presenting author: P. Bajaj
Authors: L. Nagendra, M. Samuel & M. Chandran
16:24
MR5
OCs9: HIGH-THROUGHPUT SEQUENCING OF BONE METABOLISM GENES AND THEIR ASSOCIATION WITH OSTEOPOROSIS RISK
Presenting author: P. Marozik
Author: A. Rudenka, V. Samokhovec, K. Kobets & E. Rudenka
16:32
MR5
OCs10: SARCOPENIA AND BONE HEALTH PARAMETERS IN POSTMENOPAUSAL WOMEN WITH DIFFERENT TYPES OF OSTEOPOROTI
Presenting author: N. Grygorieva
Author: A. Musiienko, D. Kurylo & A. Iniushina
18:30 - 19:30
Non-Sponsored Symposia
18:30
MR1
Sedentary Behaviour: Understanding and measuring its importance in muscle-bone health
Chairperson: Mylène Aubertin-Leheudre
18:30
MR1
Assessing sedentary behaviours using the Patient Reported Outcome Measures (PROMS)
Charlotte Beaudart
18:30
MR1
The Impact of Sedentary Behaviour on Physical Capacity across lifetime
Mylène Aubertin-Leheudre
18:30
MR1
The Impact of Sedentary Behaviour Versus Physical Activity on Bone Health
Olivier Bruyère
18:30
MR2
Potential benefits of art, music and dance on bone and muscle health
Chairpersons: Jorge Luis Alberto Morales Torres, Osvaldo Daniel Messina
18:30
MR2
Introduction: Art, Music, Dancing and Health
Osvaldo Daniel Messina
18:30
MR2
Artists and activism
Jorge Luis Alberto Morales Torres
18:30
MR2
Potential mechanisms for Argentinian Tango and fracture reduction
Kassim Javaid
18:30
MR2
Health professionals and art: For fun only?
Jorge Luis Alberto Morales Torres
18:30
MR2
Conclusions
18:30
MR3
Multiple sclerosis and osteoporosis
Chairperson: Ifigenia Kostoglou-Athanassiou
18:30
MR3
Multiple sclerosis. An autoimmune disease
Ifigenia Kostoglou-Athanassiou
18:30
MR3
Osteoporosis in the context of multiple sclerosis
Lambros Athanassiou
18:30
MR3
Treatment of osteoporosis in the context of multiple sclerosis
Panagiotis Athanassiou
18:30
MR3
Falls and prevention in multiple sclerosis
Yannis Dionyssiotis
18:30
MR4
Vertebral compression fractures: From care to augmentation
Chairpersons: Şansin Tüzün, Ülkü Akarirmak
18:30
MR4
The Impact of Vertebral Compression Fractures
Ülkü Akarirmak
18:30
MR4
Key Rehabilitation Principles in Vertebral Fractures
Şansin Tüzün
18:30
MR4
Bracing in Vertebral Fractures: Myths and Facts
Rana Terlemez
18:30
MR4
Vertebral Augmentation: Who and When?
Çağatay Öztürk
18:30
MR6
Not a cartilage, not a bone, osteoarthritis is a nerve-related condition
Chairpersons: Johanne Martel-Pelletier, Jean-Pierre Pelletier
18:30
MR6
What do we know about osteoarthritis: Does it translate between affected species?
Eric Troncy
18:30
MR6
Somatosensorial and neurological alterations in feline and canine osteoarthritis
Aliénor Delsart
18:30
MR6
Evidence-based efficacy in managing osteoarthritis in companion animals
Eric Troncy
18:30
MR7
Treatment of moving targets: from guidelines into practice
Chairperson: Bruno Muzzi Camargos
18:30
MR7
Guidelines addressing imminent risk strategies
Andrès Felipe Coy Barrera
18:30
MR7
Treatment discontinuation and intermittent use of bisphosphonates
Geraldine Altamar
18:30
MR7
Sequential and combination therapies mostly supported or avoided
Bruno Muzzi Camargos
18:30
MR8
Bone health in patients with prostate cancer on androgen deprivation therapy
Chairpersons: Jean-Jacques Body, René Rizzoli
18:30
MR8
Bone health in patients with non-metastatic prostate cancer on androgen deprivation therapy (ADT) – an Overview
Nicola Napoli
18:30
MR8
Summary of the evidence on bone agents in patients with prostate cancer on ADT
Marlene Chakhtoura
18:30
MR8
Recommendations for the management of patients with prostate cancer on ADT
David Kendler
18:30
MR10
Implementing and maintaining FLS services: (painful) Lessons learned from working with resource constraints and attempting to overcome hurdles
Chairperson: Maria Luisa Brandi
18:30
MR10
Opening Remarks
Maria Luisa Brandi
18:30
MR10
Lessons learned from implementing and maintaining FLS in Singapore
Manju Chandran
18:30
MR10
Lessons learned from mentorship in Switzerland
Thierry Chevalley
18:30
MR10
Navigating Challenges in the Fight For Fracture Liaison Services in South Africa
Teréza Hough
18:30
MR10
Panel Discussion and Closing Remarks

Saturday April 12 th - CEST Timezone

08:00 - 09:00
Non-Sponsored Symposia
08:00
MR4
Patient-centred approach to Sarcopenia: from standard of care to digital technologies
Chairpersons: Maria Luisa Brandi, Giovanni Iolascon
08:00
MR4
The global burden of Sarcopenia
Francesca Gimigliano
08:00
MR4
Multimodal exercise and nutrition: the pillars of Sarcopenia treatment
Giovanni Iolascon
08:00
MR4
Digital Technologies in Sarcopenia Treatment: the right therapy for the right patient
Antimo Moretti
08:00
MR4
Closing remarks
08:00
MR1
Comprehensive Care for Pediatric Bone Fragility
Chairperson: Leith Zakraoui
08:00
MR1
Bone fragility and osteoporosis in children and adolescents: when and how to diagnose it?
Yasmine Makhlouf
08:00
MR1
Bone fragility and osteoporosis in children and adolescents: when and how to treat it?
Saoussen Miladi
08:00
MR1
Discussion / Q&A
08:00
MR2
Osteoporosis and Complex Regional Pain Syndrome (CRPS)
Chairperson: Ayșe A. Küçükdeveci
08:00
MR2
A significant problem following osteoporotic fractures: Complex Regional Pain Syndrome
Yeșim Gökçe-Kutsal
08:00
MR2
Can we treat CRPS by pharmacological agents?
Yeșim Kirazlı
08:00
MR2
The role of non-pharmacological approaches in the management of CRPS
Ayșe A. Küçükdeveci
08:00
MR3
The evolution of post fracture care services in LATAM pre and post CTF mentorship programme
Chairpersons: Osvaldo Daniel Messina, Willem Lems
08:00
MR3
Qualitative and quantitative change in FLS/PFC in LATAM. An overview
J. Francisco Torres Naranjo
08:00
MR3
Key Performance Indicators of PFC/FLS in LATAM. Expected outcomes based on BC in Mexico and Colombia
Adriana Medina
08:00
MR3
Successful country specific strategies to improve and increase the number of FLS
Edgar Castro Osorio
08:00
MR3
Challenges ahead. Gathering key data for monitoring performance and improving quality of PFC/FLS. Country specific dataset. Experience of the Argentine Hip Fracture Registry: Pasos® Program
Maria Diehl
08:00
MR8
Pregnancy and lactation, a challenge for the Bone and Muscle Health
Chairperson: Yasser El Miedany
08:00
MR8
Pregnancy, and lactation a challenge for the skeleton
Naglaa Ali
08:00
MR8
Movement recommendations for Pregnant and lactating women
Mohamed Hassan Abu-Zaid
08:00
MR10
Abdominal aortic calcification and musculoskeletal health
Chairperson: Peter R. Ebeling
08:00
MR10
Abdominal aortic calcification, what it is and why it is important
Joshua R. Lewis
08:00
MR10
Abdominal aortic calcification and musculoskeletal outcomes
Pawel Szulc
08:00
MR10
Abdominal aortic calcification as a novel risk factor for falls and fractures in routine clinical practice
William D. Leslie
08:00
MR10
Provision of abdominal aortic calcification results to patients
John T. Schousboe
08:00 - 09:00
MR5
ISGE-ESCEO joint Symposium Session: The gynecologist and bone: A tale of woman's health
Chairpersons: Andrea Riccardo Genazzani, Şansin Tüzün
08:00
MR5
The role of sex steroids in the health of the musculoskeletal system: a lifetime journey
Andrea Riccardo Genazzani
08:00
MR5
When the ovaries fail early: protecting the bone
Svetlana Vujovic
08:00
MR5
Menopause and the bone: a matter for gynecologists
Stefano Lello
08:00 - 09:00
MR6
ESCEO Symposium: Treatment of osteoporosis and osteoarthritis in the oldest old
Chairpersons: Andrea Laslop, René Rizzoli
08:00
MR6
Specific considerations for the management of osteoporosis in the oldest old
Nicholas C. Harvey
08:00
MR6
Specific considerations for the management of osteoarthritis in the oldest old
Philip Conaghan
08:00
MR6
Discussion leader
Carla Torre
08:00 - 09:00
MR7
DVO-ESCEO Symposium: Special aspects of osteoporosis
Chairpersons: Ralf Schmidmaier, Olivier Bruyère
08:00
MR7
The role of bone anabolic treatment in the geriatric population
Ralf Schmidmaier
08:00
MR7
Management of pregnancy associated osteoporosis
Peyman Hadji
08:00
MR7
Osteonecrosis of the jaw: novel insights and current status
Sven Otto, Philipp Poxleitner, Katharina Obermeier
08:00
MR7
Dealing with atypical femur fractures
Andreas Kurth
09:00 - 10:30
Auditorium A
Scientific Session IV
Chairpersons: Manju Chandran, Peter R. Ebeling
09:00
Auditorium A
Plenary Lecture
Advances in personalized fracture risk assessment: FRAX and beyond
Nicholas Harvey
Have a sneak peek
09:30
Auditorium A
Oral communications selected from abstracts
OC19: RELATIONSHIP BETWEEN COMORBIDITY, PHYSICAL ACTIVITY AND FRAILTY DIFFER ACCORDING TO EDUCATIONAL ATTAINMENT: FINDINGS FROM THE SOUTHAMPTON LONGITUDINAL STUDY OF AGEING (SALSA)
Presenting author: F. Laskou
Author: L. D. Westbury, F. Kirkham-Wilson, G. Bevilacqua, N. R. Fuggle, E. M. Dennison, P. Aggarwal & H. P. Patel
09:40
Auditorium A
Oral communications selected from abstracts
OC20: RELATIONSHIPS BETWEEN CHANGE IN SEX HORMONES WITH CHANGE IN MEASURES OF SARCOPENIA: A LONGITUDINAL STUDY IN COMMUNITY DWELLING OLDER MEN
Presenting author: S. Hills
Author: T. A. Mansfield, P. Cawthon, N. E. Lane & E. S. Orwoll
09:50
Auditorium A
Oral communications selected from abstracts
OC21: OSTEOSARCOPENIA AS A RISK FACTOR FOR DEPRESSION: LONGITUDINAL FINDINGS FROM THE SHARE STUDY
Presenting author: N. Veronese
Author: F. S. Ragusa, S. Sabico, L. Dominguez, M. Barbagallo, G. Duque, L. Smith & N. Al-Daghri
10:00
Auditorium A
Oral communications selected from abstracts
OC22: PSYCHOMETRIC PROPERTIES OF THE SARQOL QUESTIONNAIRE: A SYSTEMATIC REVIEW AND META-ANALYSIS
Presenting author: C. Beaudart
Authors: C. Demonceau, C. Brabant, E. Shukuru, M. Alokail, N. Al-Daghri, Y. Rolland, I. Bautmans, J. M. Bauer, A. Cherubini, A. J. Cruz-Jentoft, B. Dawson-Hughes, R. A. Fielding, N. C. Harvey, F. Landi, M. Visser, G. Duque, R. Rizzoli, J.-Y. Reginster & O. Bruyère
10:10
Auditorium A
Oral communications selected from abstracts
OC23: BIOLOGICAL AGE-ACCELERATION ASSOCIATIONS WITH GRIP STRENGTH LEVEL AND LONGITUDINAL CHANGE: FINDINGS FROM THE HERTFORDSHIRE COHORT STUDY
Presenting author: N. Fuggle
Author: L. D. Westbury, N. Kitaba, J. W. Holloway & E. M. Dennison
10:20
Auditorium A
Presentation of the ESCEO-IOF Pierre Meunier Young Scientist Award
René Rizzoli
10:30 - 12:15
Auditorium A
Scientific Session V
Chairpersons: Şansin Tüzün, Ambrish Mithal
10:30
Auditorium A
Presentation of the IOF Olof Johnell Science Award
Nicholas C. Harvey
10:35
Auditorium A
Presentation of the ESCEO-IOF Young Investigator Awards
Jean-Yves Reginster, Nicholas Harvey
10:40
Auditorium A
Presentation of the 2025 ESCEO-Aging Clinical and Experimental Research Award
Nicola Veronese, Valentina Corio, Jean-Yves Reginster
10:45
Auditorium A
Plenary Lecture
MicroRNAs: novel risk predictors in musculoskeletal disease?
Luigi Gennari
Have a sneak peek
11:15
Auditorium A
Oral communications selected from abstracts
OC24: TREATMENT-RELATED CHANGES IN TOTAL HIP BONE MINERAL DENSITY AND FRACTURE RISK REDUCTION FOR TRIALS WITH ACTIVE CONTROL AND SEQUENTIAL THERAPY: THE FNIH-ASBMR-SABRE PROJECT
Presenting author: T. Vilaca
Author: L. Lui, M. Schini, S. Ewing, A. Thompson, E. Vittinghoff, D. C. Bauer, D. M. Black & M. L. Bouxsein
11:25
Auditorium A
Oral communications selected from abstracts
OC25: THE PREVALENCE OF VERTEBRAL FRACTURES AND ASSOCIATED FACTORS IN THE GAMBIA, ZIMBABWE AND SOUTH AFRICA
Presenting author: K. Ward
Authors: L. Gates, C. M. Pearse, A. Burton, T. Manyanga, M. K. Jallow, B. Cassim, C. Grundy, H. Wilson, B. Mbanjwe, F. Paruk, Y. Madele, E. M. Clark, R. A. Ferrand, N. J. Crabtree & C. L. Gregson
11:35
Auditorium A
Oral communications selected from abstracts
OC26: ENHANCING FRACTURE RISK PREDICTION: A COHORT-SPECIFIC MODEL INTEGRATING FRAXPLUS® VARIABLES FOR IMPROVED ACCURACY AND RECLASSIFICATION
Presenting author: M. Zoulakis
Authors: H. Johansson, N. C. Harvey, K. F. Axelsson, H. Litsne, L. Johansson, M. Schini, L. Vandeput, E. V. McCloskey, J. A. Kanis & M. Lorentzon
11:45
Auditorium A
Oral communications selected from abstracts
OC27: ENGAGEMENT WITH AND TOLERABILITY OF AUGMENTED REALITY (AR) EXERGAMES AMONG OLDER WOMEN WITH OSTEOPOROSIS: RESULTS FROM A CLINICAL TRIAL
Presenting author: E. Thuilier
Author: J. J. Carey, B. Whelan, M. Fitzgerald, J. Dingliana, M. Dempsey, S. Biggins & A. Brennan
11:55
Auditorium A
Oral communications selected from abstracts
OC28: EFFECTS OF ANTIDIABETETIC TREATMENTS ON FRACTURE RISK
Presenting author: G. Cavati
Author: F. Pirrotta, E. Ceccarelli, G. Dipasquale, M. Garofalo, P. Cardamone, D. Merlotti & L. Gennari
12:05
Auditorium A
Oral communications selected from abstracts
OC29: GLP-1 RECEPTOR AGONISTS AND RISK OF BONE FRACTURES IN ELDERLY PEOPLE WITH TYPE 2 DIABETES
Presenting author: P. Rotman-Pikielny
Author: M. Kasher Meron, T. Hornik-Lurie & G. Twig
14:00 - 15:00
Poster Viewing Session II
14:00 - 15:00
Meet-The-Expert Session
14:00
MR4
Biochemical markers of bone turnover: when and which?
Etienne Cavalier
14:00
MR1
Vaccination and musculoskeletal disorders
Stefania Maggi
14:00
MR2
Osteoporosis management in transgender patients
Jean-Marc Kaufman
14:00
MR3
Is there a role for SYSADOAs in the management of osteoarthritis ?
Olivier Bruyère
14:00 - 15:00
Podium
Oral presentations of selected posters
Chairperson: Elizabeth M. Curtis
14:00
Podium
OP11 - P1425: EVALUATING THE PRAGMATISM OF SARCOPENIA CLINICAL TRIALS USING PRECIS-2: A SYSTEMATIC REVIEW
Presenting author: S. Van Heden
Author: Z. Baoubbou, D. Sanchez-Rodriguez & C. Beaudart
14:06
Podium
OP12 - P1387: REFINING EARLY DETECTION OF LOW BONE MINERAL DENSITY: A DEEP LEARNING MODEL FOR OSTEOPENIA SCREENING USING CHEST RADIOGRAPHS
Presenting author: S. Park
Author: J. Park, M. Kim & H.-J. Bae
14:12
Podium
OP13 - P147 CALCIUM ISOTOPE RATIOS IN SERUM INFORM ON SKELETAL CALCIUM BALANCE IN PATIENTS ON DIALYSIS
Presenting author: A. Eisenhauer
Author: R. Shroff, M. Müller, A. Heuser, A. Kolevica, P. D´haese, I. Jochmans, E. Cavalier & P. Evenepoel
14:18
Podium
OP14 - P1025: ASSOCIATIONS BETWEEN BODY COMPOSITION, EXERCISE, DIET, SHORT-CHAIN FATTY ACIDS, AND BONE LOSS IN EARLY POSTMENOPAUSAL WOMEN
Presenting author: M. Vilar Geraldi
Author: G. Gregori, L. Johansson, U. Hjertonsson, E. Brättemark & M. Lorentzon
14:24
Podium
OP15 - P144: CALCIUM ISOTOPES AS A NOVEL BIOMARKER FOR VASCULAR CALCIFICATION IN CKD: IMPLICATIONS FOR OSTEOPOROSIS MANAGEMENT
Presenting author: A. Dosseto
Author: A. Fuller, A. Borst, T. Tacail, K. Lambert & H. Cheick Hassan
14:30
Podium
OP16 - P776: FILLING GAPS IN TELEREHABILITATION: VALIDATING REMOTE SYNCHRONOUS AND ASYNCHRONOUS ASSESSMENTS OF PERFORMANCE-BASED OUTCOMES
Presenting author: Z. Boos
Author: K. Mullen, L. Muhammad, M. K. Alshahrani & D. Pinto
14:36
Podium
OP17 - P736: THE FIRST COMPARISON OF HIP FRACTURE INCIDENCE ACROSS 4 COUNTRIES IN AFRICA
Presenting author: K. Ward
Authors: C. L. Gregson, H. Wilson, A. Burton, M. K. Jallow, B. Trawally, L. S. Gates, T. Manyanga, J. Masters, R. A. Ferrand, M. Costa & K. Marenah
14:42
Podium
OP18 - P498: DIFFERENTIAL ANALYSIS OF LUMBAR SPINE BONE MINERAL DENSITY AND TRABECULAR BONE SCORE IN HYPOPHOSPHATASIA PATIENTS WITH BIALLELIC VS MONOALLELIC ALPL GENOTYPE
Presenting author: F. Genest
Author: K. Hind, M. De Gruttola, D. Hans & L. Seefried
14:48
Podium
OP19 - P538: WHICH THRESHOLD VALUES OF CROSSLAPS TO TARGET TO PREVENT BONE LOSS AT 1 AND 2 YEARS AFTER DENOSUMAB DISCONTINUATION. THE REOLAUS STUDY
Presenting author: G. Liebich
Author: E. Gonzalez-Rodriguez & O. Lamy
14:54
Podium
OP20 - P1044: ABALOPARATIDE INCREASES DISTAL FEMUR BMD POST TOTAL KNEE ARTHROPLASTY
Presenting author: N. Binkley
Author: D. Krueger, G. Borchardt, B. Nickel & P. A. Anderson
14:00 - 15:00
MR10
Educational Lecture
14:00
MR10
Osteoporosis in inflammatory rheumatic musculoskeletal diseases (iRMDs)
Giovanni Adami
14:00 - 15:00
MR5
EuGMS-ESCEO symposium: Fragility fractures: One size fits all?
Chairpersons: Nathalie van der Velde, Alvaro Casas Herrero
14:00
MR5
Preventing fragility fractures in the oldest old: special considerations?
Nathalie van der Velde
14:00
MR5
Preventing fragility fractures: similarities and differences in approaches between LMICs and Europe
Celia Gregson
14:00
MR5
Integrating fall risk prevention within fracture management: practical steps to optimize implementation
Tahir Masud
14:00 - 15:00
MR6
ESCEO-OARSI Joint Symposium: Early knee osteoarthritis: Classification criteria for research and diagnostic criteria for clinical use
Chairpersons: Jean-Yves Reginster, Martin Englund
14:00
MR6
Classification criteria of early-stage symptomatic knee osteoarthritis: updates of the OARSI initiative
Armaghan Mahmoudian
14:00
MR6
Diagnostic criteria for early knee osteoarthritis: Opportunities and challenges
Jos Runhaar
14:00 - 15:00
MR7
ESCEO Symposium: Novel approaches to the stratified management of knee osteoarthritis: State of the art
Chairpersons: Ali Mobasheri, Roland Chapurlat
14:00
MR7
The delineation of endotype and phenotype to identify the patients with knee osteoarthritis who should be treated
Philip Conaghan
14:00
MR7
The role of biomarkers (imaging, biological) to identify the patients with knee osteoarthritis who should be treated
Francis Berenbaum
14:00
MR7
Discussion leader
Ali Mobasheri, Roland Chapurlat, Philip Conaghan, Francis Berenbaum
14:00 - 15:00
MR8
Educational Lecture
14:00
MR8
Biosimilars in osteoporosis management
Stuart L. Silverman
15:00 - 16:45
MR5
Committee of Scientific Advisors Special Session: Future opportunities in the management of osteoporosis
Chairpersons: Eugene McCloskey, Etienne Cavalier
15:00
MR5
Barriers and solutions for global access to osteoporosis management
John A. Kanis
15:00
MR5
Approaches to risk-based Population Screening: Insights from the ROSE study and FREM development in Denmark
Katrine Rubin
15:00
MR5
The Fact and Fiction of AI in Osteoporosis
Nicholas Fuggle
15:00 - 17:00
Auditorium A
Scientific Session VI
Chairpersons: Patricia Clark, Radmila Matijevic
15:00
Auditorium A
Plenary Lecture
Novel concepts: assessment of intrinsic capacity
Bess Dawson-Hughes
Have a sneak peek
15:30
Auditorium A
Oral communications selected from abstracts
OC30: EFFECTS OF A REMOTELY-DELIVERED FUNCTIONAL RESISTANCE AND IMPACT TRAINING PROGRAM VERSUS WALKING ON PHYSICAL FUNCTION IN OLDER ADULTS WITH OBESITY UNDERGOING CALORIC RESTRICTION: A 6-MONTH RANDOMISED CONTROLLED TRIAL
Presenting author: D. Scott
Author: P. Jansons, C. Glavas, S. Sood, M. Hunegnaw, J. Ryan, J. Mesinovic, R. Daly, A. Zengin, E. George & P. Ebeling
15:40
Auditorium A
Oral communications selected from abstracts
OC31: MATERNAL BONE MINERAL DENSITY AT 4 YEARS POST-DELIVERY IS NOT AFFECTED BY PREGNANCY VITAMIN D SUPPLEMENTATION
Presenting author: R. Moon
Author: S. D'Angelo, E. M. Curtis, K. A. Ward, K. M. Godfrey, C. Cooper & N. C. Harvey
15:50
Auditorium A
Oral communications selected from abstracts
OC32: USING PROBIOTICS TO SUPPORT BONE HEALTH IN POSTMENOPAUSAL WOMEN: A RANDOMIZED, DOUBLE-BLIND, PARALLEL, PLACEBO-CONTROLLED, MULTI-CENTRE STUDY
Presenting author: J. Yumol
Author: S. Binda, V. Nagulesapillai & W. E. Ward
16:00
Auditorium A
Oral communications selected from abstracts
OC33: RELATIONSHIPS BETWEEN MICRORNAS AND CORTICAL BONE IN CHRONIC KIDNEY DISEASE
Presenting author: T.L. Nickolas
Author: C. Metzger, N. Chen, D. Mcmahon, M. Allen, R. Moyses & S. Moe
16:10
Auditorium A
Oral communications selected from abstracts
OC34: FRAGILITY FRACTURES MANAGEMENT IN PREGNANCY BY REMS TECHNOLOGY: THE PREGNANCY OSTEOPOROSIS INITIATIVE (POI)
Presenting author: V. Degennaro
Authors: T. Bignardi, A. Bulfoni, I. Cetin, A. Cromi, G. Franzoni, F. Ghezzi, M. Ossola, H. Valensise, T. Ghi & M. L. Brandi
16:20
Auditorium A
Oral communications selected from abstracts
OC35: INTERACTIONS BETWEEN CALCIUM AND PROTEIN INTAKES, AND OSTEOPOROSIS MEDICATIONS ON HIP BONE STRENGTH: AN OBSERVATIONAL STUDY IN OLDER WOMEN
Presenting author: M. Papageorgiou
Author: Y. Gugler, S. Ferrari, R. Rizzoli, P. Zysset & E. Biver
16:30
Auditorium A
Plenary Lecture
Osteoimmunology: a legacy discipline?
Willem Lems
Have a sneak peek
17:00 - 18:00
Auditorium B
Educational Lecture
17:00
Auditorium B
Pregnancy - and lactation-related osteoporosis
Maria Luisa Brandi
17:00 - 18:00
Non-Sponsored Symposia
17:00
MR1
Bone, Muscle and Fat interractions in neurodisabled persons
Chairperson: Ifigenia Kostoglou-Athanassiou
17:00
MR1
Introduction in bone, muscle and fat interactions
Ifigenia Kostoglou-Athanassiou
17:00
MR1
(Osteo)Sarcopenia and sarcopenic obesity in neurodisabled individuals
Yannis Dionyssiotis
17:00
MR1
Sarcopenia in Hemiplegia and Stroke
Maria Papadatou
17:00
MR1
Discussion in bone, muscle and fat interactions
Ifigenia Kostoglou-Athanassiou
17:00
MR2
From bone metastasis to osteoporosis - Joint IOF and CABS Symposium (Cancer and Bone Society)
Chairpersons: Patricia Juarez-Camacho, Peyman Hadji
17:00
MR2
Decoding skeletal complications in bone metastases
Patricia Juarez-Camacho
17:00
MR2
Treatment of bone metastasis – state of the art 2025
Cyrille Confavreux
17:00
MR2
CTIBL – size of the problem and treatment options?
Peyman Hadji
17:00
MR3
The Latest in Artificial Intelligence in Osteoporosis: From Large Language Models to Computer Vision
Chairperson: Nicholas Fuggle
17:00
MR3
What are ‘A Large Language ModeIs’ and how can they be deployed in osteoporosis?
Nicholas Fuggle
17:00
MR3
Health Equity considerations when using AI in Clinical Practice
Joe Alderman
17:00
MR3
AI for vertebral fracture screening: A UK perspective – An update from the ADOPT study
Kassim Javaid
17:00
MR4
Improving and Enhancing DXA Practices; A joint symposium with ISCD and IOF
Chairpersons: Nicholas C. Harvey, William D. Leslie
17:00
MR4
DXA Quality, Common Errors and Clinical Impact
Neil Binkley
17:00
MR4
The ABCs of DXA and How to Improve fractures
Diane Krueger
17:00
MR4
Expanding DXA Functionality to Enhance Clinical Care
Kate Ward
17:00
MR5
The challenge of oral health in patients with osteoporosis: A pragmatic approach
Chairpersons: Jorge Luis Alberto Morales Torres, Osvaldo Daniel Messina
17:00
MR5
Introduction: Oral health and bone health. A quotidian dilemma?
Jorge Luis Alberto Morales Torres, Osvaldo Daniel Messina
17:00
MR5
The overall impact of oral health in the elderly
Hugo Gutiérrez Hermosillo
17:00
MR5
Osteoporotic fractures and MRONJ: Sobering statistics
Francisco Fidencio Cons Molina
17:00
MR5
Improving oral screening: the Oral Health Assessment Tool
Jorge Luis Alberto Morales Torres
17:00
MR5
Discussion: Whose task is it to identify oral health?
17:00
MR6
Conclusions
Jorge Luis Alberto Morales Torres
17:00
MR6
Skeletal fragility: The role of vitamin D and K in CKD patients
Chairpersons: Maria Fusaro, Thomas L. Nickolas
17:00
MR6
Vitamin D: from native to active form in CKD-associated
Rosa Moyses
17:00
MR6
Vitamin K: instructions for use in skeletal fragility
Maria Fusaro
17:00
MR6
The Statistician in detecting fraud and negligence in clinical trials
Giovanni Tripepi
17:00
MR6
Vitamin D in Skeletal Fragility: Clinical Case
Hanne Jorgensen
17:00
MR6
Discussion
17:00
MR7
Breaking Barriers and Advancing Bone Health for People with Intellectual Disability
Chairperson: Éilish Burke
17:00
MR7
The Silent Epidemic of Osteoporosis among Adults with Intellectual Disabilities
Éilish Burke
17:00
MR7
Exploring Dietary Deficiencies in Adults with Intellectual Disabilities Contributing to Poor Bone Health
Judy Ryan
17:00
MR7
Sedentary Behaviour and its Implications for the Bone Health of those with Intellectual Disability
Louise Lynch
17:00
MR7
Innovative Solutions: The Echolight Rems Device for Accessible Bone Health Screening for Adults With Intellectual Disability
Anne Power
17:00
MR8
New horizons in sarcopenia: From pediatric reference values to emerging therapeutic advances
Chairpersons: Gulistan Bahat, Radmila Matijevic
17:00
MR8
Recognizing and managing Sarcopenia in Children: Reference muscle mass values from a European cohort
Taha Kizilkurt
17:00
MR8
Molecular Insights, Pathways and Candidates for Novel Interventions in Sarcopenia
Serdar Ozkok

Sunday April 13 th - CEST Timezone

08:00 - 09:00
Non-Sponsored Symposia
08:00
MR3
Perioperative Bone Optimization in Arthroplasty Candidates with Osteoporosis
Chairperson: Rafael Jimenez-Umbarila
08:00
MR3
Updated Joint Positions on Perioperative Bone Optimization in Arthroplasty Candidates 2024
Roberto E. Lopez Cervantes
08:00
MR3
Current Practices, Needs, and Challenges in Periprosthetic Bone Mineral Density Assessment: Towards Standardization
J. Francisco Torres Naranjo
08:00
MR3
Current Practices and Educational Needs in Perioperative Bone Optimization for Arthroplasty Candidates: Survey Results
José Máximo Gomez-Acevedo
08:00
MR4
The intimate relationship between adipose and bone tissue
Chairperson: Yannis Dionyssiotis
08:00
MR4
Adipose and bone tissue. A close relationship
Ifigenia Kostoglou-Athanassiou
08:00
MR4
Metabolic syndrome. A paradigm of the intimate relationship between adipose and bone tissue
Panagiotis Athanassiou
08:00
MR4
Metabolic syndrome and osteoporosis
Yannis Dionyssiotis
08:00
MR4
Metabolic syndrome and diet. Do they affect bone mass?
Lambros Athanassiou
08:00
MR4
Metabolic syndrome and depression
Yannis Athanassiou
08:00
MR1
Update on the Study to Advance BMD as a Regulatory Endpoint (SABRE): What Might Osteoporosis Trials look like in the Future?
Chairperson: Mary Bouxsein
08:00
MR1
Challenges of Clinical Trials for New Osteoporosis Medications
Eugene McCloskey
08:00
MR1
Evidence Supporting the Use of BMD as a Surrogate Endpoint for Fractures
Richard Eastell
08:00
MR1
Considerations for designing trials that use BMD as a Primary EndpointKyphoplasty
Dennis Black
08:00
MR2
Improving Women’s Bone Health Throughout the Lifespan
Chairpersons: Adriana Orcesi Pedro, Maria Celeste Osório Wender
08:00
MR2
Opening and Welcome from FEBRASGO
Maria Celeste Osório Wender
08:00
MR2
Bone Consequences of Premature Ovarian Insufficiency (POI)
Jaime Kulak Jr.
08:00
MR2
The Role of Hormone Therapy in the Management of Postmenopausal
Maria Celeste Osório Wender
08:00
MR2
Evaluation and management of osteopenia and osteoporosis in breast cancer survivors
Adriana Orcesi Pedro
08:00
MR7
Developing Clinical Practice Guidelines for Osteoporosis Diagnosis and Management in Middle-Income Countries: Challenges and Opportunities
Chairperson: Geraldine Altamar
08:00
MR7
Why a clinical practice guideline in a middle-income country like Colombia?
Geraldine Altamar
08:00
MR7
Challenges in the development of clinical practice guidelines in a middle-income country
Adriana Medina
08:00
MR7
Opportunities in the development of clinical practice guidelines
Monique Chalem
08:00
MR8
European and American Efforts to Educate the Public and Health Care Professionals on the Connection Between Spine and Bone Health
Chairperson: Rita Roy
08:00
MR8
Osteoporosis and the Spine Overview: Key Statistics and an Overview of the National Spine Health Foundation’s Key Patient and Health Care Professional Initiatives
Rita Roy
08:00
MR8
A Spine Surgeon Perspective on the Need for Spine and Bone Health Optimization
Paul Anderson
08:00
MR8
A European Perspective on Key Spine Surgeon Gaps in the Diagnosis and Treatment of Osteoporotic Patients
Jean Charles Le Huec
08:00
MR10
Navigating the Complex Interplay of Aging, Chronic Kidney Disease, and Osteoporosis: Case-Based Challenges and Treatment Insights
Chairpersons: Nathalie van der Velde, Tahir Masud
08:00
MR10
Setting the Stage: Understanding the Intersection of Aging, CKD, and Osteoporosis – Key Concepts and Clinical Approaches
Savas Ozturk
08:00
MR10
Managing Skeletal Fragility in the Context of CKD: Practical Insights
Richard Keen
08:00
MR10
Real-World Challenges and Personalized Strategies in Diagnosis and Treatment
Gulistan Bahat
08:00 - 09:00
MR5
ESCEO Symposium on PTH1 RA: Use of parathyroid hormone receptor agonists in the management of osteoporosis: State of the art
Chairpersons: Nicholas C. Harvey, Claudia Campusano
08:00
MR5
Pharmacological mode of action
Nicholas C. Harvey
08:00
MR5
Anti-fracture efficacy of PTH R1A
Nicola Veronese
08:00
MR5
Safety of PTH R1A in the management of osteoporosis
Elizabeth M. Curtis
08:00
MR5
Discussion leader
Bernard Cortet
08:00 - 09:00
MR6
SICOT-ESCEO-IOF Symposium: Fragility Fractures - Importance of Interdisciplinary Management
Chairpersons: Veronika Koeppen-Ursic, Marc Hanschen
08:00
MR6
Fragility Fractures of the Pelvic Ring – Minimal Invasive Treatment Options
Marc Hanschen
08:00
MR6
Decision Making in the Management of Fragility Fractures of the Acetabulum
Umberto Mezzadri
08:00
MR6
Interdisciplinary Comprehensive Care of Fragility Fractures in Germany
Veronika Koeppen-Ursic
08:00
MR6
15 Years of Experience with Atypical Femoral Fractures
Jörg Schilcher
09:00 - 10:00
Poster Viewing Session III
09:00 - 10:00
Meet-The-Expert Session
09:00
MR1
Magnesium, nutrition and musculoskeletal disorders
Nicola Veronese
09:00
MR4
Osteoarthritis: a bone or a joint disorder?
Roland Chapurlat
09:00
MR2
GIOP: present and future
Giovanni Adami
09:00
MR3
Artificial intelligence in patient management
Nicholas Fuggle
09:00 - 10:00
MR6
ESCEO-EMAS Joint Symposium: Risks and management of osteoporosis in menopausal women
Chairpersons: Angelica Lindén Hirschberg, Radmila Matijevic
09:00
MR6
Association between early menopause and fracture risk
Panagiotis Anagnostis
09:00
MR6
Ovarian volume and bone mineral density in postmenopausal women
Eleni Armeni
09:00
MR6
What do current guidelines recommend about MHT and osteoporosis prevention in menopausal women?
Angelica Lindén Hirschberg
10:00 - 12:00
Auditorium A
Scientific Session VII
Chairpersons: Lakshmi Nagendra, Claudia Campusano, Manju Chandran
10:00
Auditorium A
Plenary Lecture
When should we consider moving from medical to surgical management in osteoarthritis of the knee and hip?
Philip Conaghan
10:40
Auditorium A
Oral communications selected from abstracts
OC36: A NATIONAL SURVEY OF AUSTRALIAN PRIMARY CARE CLINICIANS’ KNOWLEDGE, BELIEFS, ATTITUDES, PRACTICES, PERCEPTIONS OF RESPONSIBILITY AND BARRIERS AND ENABLERS TO IDENTIFICATION AND MANAGEMENT OF SARCOPENIA
Presenting author: R.M. Daly
Authors: D. Scott, N. Kiss, M. Tieland, B. J. Braguley, J. J. Fyfe & R. Manocha
10:50
Auditorium A
Oral communications selected from abstracts
OC37: AUTOMATED ABDOMINAL AORTIC CALCIFICATION EXTENT IS ASSOCIATED WITH MUSCLE COMPOSITION, STRENGTH AND SARCOPENIA: THE UK BIOBANK IMAGING STUDY
Presenting author: M. Sim
Author: A. Gebre, C. Smith, J. Webster, A. Saleem, S. Z. Gilani, G. Duque, E. L. Duncan, N. K. Hong, P. Raina, D. P. Kiel, J. P. Kemp, Y. Zhong, R. M. Daly, J. T. Schousboe, W. D. Leslie, R. L. Prince, N. C. Harvey & J. R. Lewis
11:00
Auditorium A
Oral communications selected from abstracts
OC38: ROMOSOZUMAB AND DENOSUMAB COMBINATION THERAPY IN POSTMENOPAUSAL OSTEOPOROSIS
Presenting author: G. Adami
Author: F. Pollastri, C. Benini, A. Piccinelli, F. Montanari, D. Gatti, O. Viapiana & M. Rossini
11:10
Auditorium A
Oral communications selected from abstracts
OC39: FIVE-YEARS OF CALCIUM SUPPLEMENTATION IS NOT ASSOCIATED WITH LONG-TERM RISK OF DEMENTIA IN OLDER WOMEN: POST-HOC ANALYSIS FROM A RANDOMISED CLINICAL TRIAL
Presenting author: M. Sim
Author: N. Ghasemifard, J. R. Lewis, S. Radavelli-Bagatini, S. M. Laws, B. Stephan, K. Zhu, J. M. Hodgson & R. L. Prince
11:20
Auditorium A
Oral communications selected from abstracts
OC40: THE EFFECT OF DENOSUMAB ON FUNCTIONAL RECOVERY IN OLDER PATIENTS UNDERGOING SURGICAL FIXATION FOR INTERTROCHANTERIC FEMORAL FRACTURE: A RANDOMIZED, PLACEBO-CONTROLLED TRIAL
Presenting author: P. Athakitkarnka
Author: E. Vanitchareonkul, A. Unnanuntana & P. Chotiyarnwong
11:30
Auditorium A
Plenary Lecture
Successful fracture healing: do osteoporosis and its treatment matter?
Manju Chandran
Have a sneak peek
12:00 - 13:00
Non-Sponsored Symposia
12:00
MR1
HIV, bone quality and quantity, and fracture risk: insights from studies in Zimbabwe and South Africa
Chairpersons: Lisa Micklesfield, Teréza Hough
12:00
MR1
HIV and it’s treatments on fracture risk: a scoping review
Celia Gregson
12:00
MR1
Fractures E3 focussing on vertebral fractures
Kate Ward
12:00
MR1
Clinical risk factors associated with fracture risk in middle-aged men and women from Soweto, Johannesburg: findings from the Middle-aged Soweto Cohort (MASC)
Lisa Micklesfield
12:00
MR1
The influence of HIV on bone quality, quantity and fracture risk in midlife women: findings from a cross-sectional study in Zimbabwe
Celia Gregson
12:00
MR2
Potential driving mechanisms behind sarcopenia: where are we now?
Chairperson: Evelien Gielen
12:00
MR2
Exploring the role of inflammageing in sarcopenia – a quick overview
Jolan Dupont
12:00
MR2
The gut-muscle axis in sarcopenia: bridging gut microbiota, inflammation and diet
Laurence Lapauw
12:00
MR2
Sarcopenia and the Brain: unravelling the Muscle-Brain Axis in the development and treatment of Sarcopenia
Nadjia Amini
12:00
MR2
Conclusion and discussion of the symposium
Evelien Gielen
12:00
MR3
Fibromyalgia. Pain and musculoskeletal manifestations
Chairperson: Panagiotis Athanassiou
12:00
MR3
Fibromyalgia as a systemic autoimmune disease affecting the bone
Panagiotis Athanassiou
12:00
MR3
Fibromyalgia in the context of autoimmune rheumatic diseases
Lambros Athanassiou
12:00
MR3
Fibromyalgia in the context of autoimmune thyroid disease
Ifigenia Kostoglou-Athanassiou
12:00
MR3
Fibromyalgia and pain
Ippokratis Sanidis
12:00
MR3
Fibromyalgia, pain and psychological implications
Yannis Athanassiou
12:00
MR4
Managing the Discontinuation of Denosumab Therapy
Chairperson: David Kendler
12:00
MR4
Denosumab: Long-term Therapy and Discontinuation
Michael McClung
12:00
MR4
Managing Denosumab Discontinuation in Patients with Osteoporosis
Bente Langdahl
12:00
MR4
Managing the Discontinuation of Denosumab in Patients on Hormone Ablative Therapy for Non-metastatic Cancer with Osteoporosis
Yumie Rhee
12:00
MR5
The Importance of Osteosarcopenia Today
Chairpersons: Nasser Al-Daghri, Gustavo Duque
12:00
MR5
Epidemiological facts about osteosarcopenia
Shaun Sabico
12:00
MR5
The molecular pathways of osteosarcopenia
Gustavo Duque
12:00
MR5
How to treat osteosarcopenia
Nicola Veronese
12:00
MR6
Latin American Patients’ perceptions on osteoporosis diagnosis and treatment. The IOF Patient Advisory Group in Latin America
Chairperson: Joan Levin
12:00
MR6
The LATAM PAG materials and methods
Patricia Clark
12:00
MR6
Key findings and results
Adriana Orcesi Pedro
12:00
MR6
Listening to the patient’s voice
Roberto E. Lopez Cervantes
12:00
MR6
Question & Answer
12:00
MR6
Closing
12:00
MR7
Where Do We Stand in the Non-Pharmacological Treatment of Osteoporosis?
Chairperson: Pinar Borman
12:00
MR7
Introduction to Non-Pharmacological Treatments in Osteoporosis
Pinar Borman, Belgin Karaoglan
12:00
MR7
Exercise in Osteoporosis
Aysegul Yaman
12:00
MR7
Physical Therapy Modalities in Osteoporosis and its complications
Sefa Gümrük Aslan
12:00
MR7
Microbiota and Diet in Osteoporosis
Pinar Borman
12:00
MR8
The effect of hormonal treatment and cancer on bone health
Chairperson: Giuseppe Guglielmi
12:00
MR8
Diagnostics methods for studying the bone damage in cancer patients
Li-Gang Cui
12:00
MR8
How can short-term monitoring be helpful to assess bone fragility in breast cancer patients?
Elena Bischoff
12:00
MR8
Management of bone fragility in prostate cancer patients
Giuseppe Guglielmi
12:00
MR10
Sleep apnea and Sarcopenia: a dream combo
Chairperson: Bruno Muzzi Camargos
12:00
MR10
Sleep disorders and sarcopenia - Assessment by Polysomnography
Oslei De Matos
12:00
MR10
Sarcopenia and Osteoporosis - Assessment by Dual X-Ray Absorptiometry (DXA)
Bruno Muzzi Camargos
12:00
MR10
Questions and Answers